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Abstract We examined the mechanism(s) for HERG channel
dysfunction in an S818L mutation in the HERG C-terminus
using the heterologous expression system in Xenopus oocytes.
Injection of S818L cRNA alone did not produce expressed
currents. Coinjection of an equal amount of S818L cRNA with
wild-type (WT) cRNA into oocytes did not exhibit apparent
dominant-negative suppression. However, coinjection of excess
amounts of S818L cRNAs with WT cRNA into oocytes
decreased HERG current amplitudes and shifted the voltage
dependence of activation to negative potentials, accelerated its
activation and deactivation. The data suggest that S818L alone
cannot form functional channels, whereas S818L subunits can, at
least in part, coassemble with WT subunits to form hetero-
tetrameric functional channels, and imply that the HERG C-
terminus may contain a domain involving the activation^
deactivation process of the channel. These findings may provide
new insights into the structure^function relationships of the
HERG C-terminus. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Familial long QT syndrome (LQTS) is an inherited disease
characterized by prolongation of ventricular repolarization,
frequently associated with lethal ventricular arrhythmias re-
sulting in catastrophic sudden death. Genetic analyses have
revealed that the autosomal-dominant trait form of LQTS,
Romano^Ward syndrome, is genetically heterogeneous and
is linked to at least ¢ve di¡erent loci (LQT1^LQT5) [1^5].
The human ether-a-go-go related gene, HERG, is the gene
responsible for one form of long QT syndrome (LQT2) and
encodes the pore-forming subunit of the rapidly activating
delayed recti¢er potassium channel (IKr) in cardiac cells,
which is the major determinant of action potential duration
[2,6^8].
Many mutations at di¡erent sites in HERG have been iden-
ti¢ed in LQT2 patients [2,9^13]. We and other groups have
revealed that HERG channel dysfunction in LQT2-associated
mutations can be caused by multiple mechanisms [14^22].
Some mutations cause defects in intracellular protein trans-
port to the plasma membrane [17,18]. Others can exist in the
plasma membrane thereby producing functional channels with
altered gating properties [14,16,20], gain of function due to
the altered ion selectivity [20], or non-functional channels in
the plasma membrane [17].
From the point of view of primary HERG structure, the
mechanisms for HERG channel dysfunction could, at least
in part, be characterized by the sites at which missense muta-
tions occurred. For example, mutations in the N-terminus
accelerated HERG channel deactivation [19], a mutation in
the S4 voltage sensor a¡ected the voltage dependence of acti-
vation [16], or mutations in the pore region a¡ected HERG
channel inactivation [15] or ion selectivity [20]. In contrast,
little information is available for characterizing the mecha-
nism(s) for HERG channel dysfunction caused by mutations
in the C-terminus. Only mutation V822M has been biochemi-
cally and electrophysiologically studied, in which intracellular
protein transport to the plasma membrane proved to be de-
fective [17]. Thus, although it is suggested that the HERG C-
terminus might play a signi¢cant role in cardiac repolarization
[23], mechanisms for HERG channel dysfunction in mutations
in the HERG C-terminus are not yet fully understood.
Berthet et al. [23] have recently reported mutation S818L
(substitution of serine to leucine at position 818), which is
located at the putative cyclic nucleotide binding domain in
the HERG C-terminus, in LQT2 patients. We have identi¢ed
this same mutation in Japanese LQT2 patients (unpublished
data). Thus, we examined the mechanism(s) for HERG chan-
nel dysfunction in the S818L mutation using the heterologous
expression system in Xenopus oocytes. The data suggest that
S818L HERG alone cannot form functional channels. How-
ever, S818L subunits can, at least in part, coassemble with
wild-type (WT) subunits and produce heteromultimeric func-
tional channels with altered gating properties. These ¢ndings
may provide new insights into the structure^function relation-
ships of the HERG C-terminus.
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2. Materials and methods
2.1. Generation of the S818L expression construct
The HERG cDNA clone subcloned into the BamHI^EcoRI site of a
pGH19 vector was a gift from Dr. Gail A. Robertson (University of
Wisconsin). Amino acid substitution of serine to leucine at position
818 within the HERG C-terminus was performed by an overlap ex-
tension PCR strategy [16]. The insert region, including the cloning
sites, of the S818L HERG construct has been sequenced directly.
2.2. Oocyte handling and electrophysiology
Xenopus oocyte preparation and handling were carried out as de-
scribed previously [15,16]. Brie£y, oocytes were surgically removed
from Xenopus laevis (Hamamatsu Seibutsu) under anesthesia in ice
water, washed in Ca2-free OR2 solution containing (mmol/l) 100
NaCl, 2 KCl, 1 MgCl2, 5 HEPES and 5 Tris (pH 7.6 with HCl).
Stage V and VI oocytes were defolliculated by treatment with 2 mg/
ml collagenase (type IA, Worthington) in Ca2-free OR2 solution for
30^60 min, and washed extensively with Ca2-free OR2 solution con-
taining no collagenase. They were injected with either 40 nl of cRNA
encoding WT HERG (0.0375 ng/nl) alone or S818L HERG (0.0375^
0.375 ng/nl), or 40 nl of cRNA in combination with both WT (0.0375
ng/nl) and S818L (0.0375, 0.1125 and 0.375 ng/nl) using a 10 Wl
Drummond micropipetter modi¢ed for microinjection (Drummond
Scienti¢c). Injected oocytes were incubated for 3^5 days at 14^16‡C
in modi¢ed Barth’s solution containing (mmol/l) 88 NaCl, 1 KCl, 2.4
NaHCO3, 15 Tris, 0.3 Ca(NO3)2, 0.4 CaCl2, 0.8 MgSO4, 100 Wg/ml
sodium penicillin, and 100 Wg/ml streptomycin sulfate (pH 7.6 with
HCl).
Membrane currents were recorded from oocytes by the convention-
al two-microelectrode voltage-clamp technique using an ampli¢er
(GeneClamp 500, Axon Instruments) at a room temperature of 24^
26‡C. Current injecting and potential measuring electrodes had resis-
tances of 0.5^1.5 M6 when ¢lled with 3 mol/l KCl. Current measure-
ments were low-pass ¢ltered at 0.5 kHz. Data acquisition and analysis
were done using pClamp software (version 7, Axon Instruments) and
a TL-1A/D converter (Axon Instruments). Oocytes were perfused
continuously with a modi¢ed ND96 solution, containing (mmol/l)
96 NaCl, 2 KCl, 2.6 MgCl2, 0.18 CaCl2 and 5 HEPES (pH 7.6
with NaOH). A P/4 method was used to subtract leak and capacita-
tive currents, unless otherwise indicated. All pulse protocols are in-
dicated in the ¢gure legends.
2.3. Data analyses
pCLAMP software (Axon Instruments) was used to measure cur-
rent amplitude. To determine the voltage dependence of HERG cur-
rent activation, a least-squares algorithm on Origin software (Micro-
cal) or Excel software (Microsoft) was used to ¢t tail current
amplitudes (Itail) to a Boltzmann function in the following form:
I tail  I tailÿmax3I tailÿmax=f1 expV t3V1=2=Kg
where Itailÿmax is peak Itail, Vt is the test potential, V1=2 is the voltage
at which Itail is half of Itailÿmax; and K is the slope factor.
Curve ¢ttings were done with a least-squares algorithm on
pCLAMP software (Axon Instruments) or Origin software (Microcal).
To examine the activation time course, we used the envelope of tail
tests [16,25], and peak current amplitudes were ¢tted to a single ex-
ponential function on Origin software (Microcal).
Steady-state inactivation was analyzed as described previously
[15,16,24]. Brie£y, the corrected steady-state inactivation curves were
¢tted with a Boltzmann function in the following form:
I=Imax3Imin  1=f1 expVp3V1=2=Kg  Imin
where I is the amplitude of inactivating current corrected for deacti-
vation, Imax is the maximum of I, Imin is the minimum of I, Vp is the
prepulse potential, V1=2 is the voltage at which I is half of Imax, and K
is the inverse slope factor.
All the values are expressed as mean þ S.E.M. One-way analysis of
variance followed by a Student’s t-test was used to test for signi¢cance
(P6 0.05).
3. Results
3.1. S818L HERG alone could not form functional channels
First, we injected various amounts of S818L cRNA into
Xenopus oocytes. Although we injected up to 15 ng S818L
cRNA into oocytes, membrane currents were not di¡erent
from those in H2O-injected oocytes (Fig. 1). This indicated
that S818L alone could not form functional channels.
3.2. S818L HERG did not exhibit apparent dominant-negative
suppression
Next, as reported previously [14^16], we injected equal
amounts (1.5 ng) of WT cRNA and S818L cRNA together
into oocytes, which would render quantitative analysis feasi-
ble, and examined the characteristics of the expressed cur-
rents.
Fig. 2A,B displays representative traces of expressed cur-
rents in oocytes injected with 1.5 ng WT cRNA (WT1.5), and
1.5 ng WT cRNA plus 1.5 ng S818L cRNA (S818L/WT).
Amplitudes of expressed currents for S818L/WT were similar
to those for WT1.5 (Fig. 2C,D). The amplitude of expressed
currents measured at 370 mV following depolarizing test
pulses to +20 mV for S818L/WT (1620 þ 127 nA, n = 9) was
not much di¡erent from that for WT1.5 (1597 þ 249 nA, n = 8)
(Fig. 2D). Thus, S818L did not suppress WT HERG channel
function in a dominant-negative manner. One simple explan-
ation for this is that S818L subunits cannot participate in
tetramer formation. However, as shown in Fig. 2E, the volt-
age to achieve half activation (V1=2) for S818L/WT
Fig. 1. No functional expression of the currents in oocytes injected with S818L HERG cRNA alone. Representative currents recorded in oo-
cytes injected with 15 ng S818L cRNA (A) or with H2O (B). Depolarizing test pulses were applied from a holding potential of 380 mV to var-
ious potentials between 370 and +20 mV in 10 mV increments for 4 s, followed by a hyperpolarizing pulse to 370 mV for 4 s. The voltage
protocol is illustrated in the inset in A. Only endogenous currents were recorded. Small horizontal bar indicates zero current level.
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(339.6 þ 0.7 mV, n = 9) was shifted to negative potentials
compared with that for WT1.5 (336.6 þ 0.7 mV, n = 8)
(P6 0.05). The slope factor (K) for S818L/WT (37.8 þ 0.2
mV, n = 9) was reduced compared with that for WT1.5
(38.9 þ 0.3 mV, n = 8) (P6 0.05). This ¢nding appeared to
suggest that, although S818L did not cause dominant-negative
suppression, S818L might coassemble with the WT HERG
channel and a¡ect its voltage dependence of activation. To
further inquire into this possibility, we examined the e¡ects
of excess amounts of S818L cRNAs on WT HERG channel
properties.
3.3. Excess amounts of S818L cRNAs decreased HERG
current amplitude and modi¢ed gating properties
We injected a 3-fold (4.5 ng) and a 10-fold (10 ng) excess of
S818L cRNAs in combination with WT cRNA (1.5 ng) into
oocytes (3-S818L/WT, 10-S818L/WT, respectively) and exam-
ined the expressed currents. Fig. 3A^C displays representative
traces of expressed currents for WT1.5, 3-S818L/WT and 10-
S818L/WT. Amplitudes of expressed currents for 3-S818L/WT
and 10-S818L/WT were smaller than those for WT1.5 (Fig.
3D,E), whereas amplitudes of expressed currents in oocytes
injected with a 10-fold WT cRNA (15 ng) were much larger
than those for WT1.5 (data not shown). The amplitudes of
expressed currents measured at 370 mV following depolariz-
ing test pulses to +20 mV for 3-S818L/WT (845 þ 111 nA,
n = 8) and 10-S818L/WT (597 þ 161 nA, n = 8) were signi¢-
cantly smaller than that for WT1.5 (1918 þ 225 nA, n = 8)
(Fig. 3E). Moreover, the V1=2 for 3-S818L/WT (338.6 þ 0.6
mV, n = 8) and 10-S818L/WT (340.7 þ 0.6 mV, n = 8) were
shifted signi¢cantly to negative potentials compared with
that for WT1.5 (336.5 þ 0.8, n = 8), and the K for 3-S818L/
WT (37.5 þ 0.3 mV, n = 8) and 10-S818L/WT (36.7 þ 0.3 mV,
n = 8) were reduced signi¢cantly compared with that for
WT1.5 (38.8 þ 0.3 mV, n = 8) (Table 1, Fig. 3F). These
changes in 10-S818L/WT were more prominent than those
in 3-S818L/WT. Thus, since excess amounts of S818L cRNAs
decreased HERG current amplitude and modi¢ed the voltage
dependence of activation, we examined the e¡ect of excess
amounts of S818L cRNAs on other HERG channel kinetics.
We evaluated the activation time course of expressed cur-
rents using the envelope of tail protocol [16,25]. Fig. 4A,B
displays representative traces of expressed currents for
WT1.5 and 10-S818L/WT obtained by the envelope of tail
protocol. Fig. 4C represents the normalized tail current am-
plitudes measured at an activation voltage of 0 mV for
WT1.5, 3-S818L/WT and 10-S818L/WT. The activation time
Fig. 2. No dominant-negative suppression by coinjection of equal amounts of S818L cRNA and WT cRNA. A,B: Expressed currents in oo-
cytes injected with 1.5 ng WT cRNA (WT1.5) (A) or coinjected with 1.5 ng S818L cRNA and 1.5 ng WT cRNA (S818L/WT) (B). The voltage
protocol is illustrated in the inset in B. C: Current^voltage (I^V) relationships for peak currents recorded during depolarizing pulses for WT1.5
(F) and S818L/WT (E). D: I^V relationships for amplitudes of tail currents for WT1.5 and S818L/WT. E: Normalized I^V relationships for
amplitudes of tail currents for WT1.5 and S818L/WT.
Table 1
Parameters of activation for WT1.5, 3-S818L/WT, 10-S818L/WT
Activation
Tail (nA) V1=2 (mV) K (mV)
WT1.5 1918 þ 225 336.5 þ 0.8 38.8 þ 0.3
3-S818L/WT 845 þ 111* 338.6 þ 0.6* 37.5 þ 0.3*
10-S818L/WT 597 þ 161* 340.7 þ 0.6* 36.7 þ 0.3*
Tail : amplitude of tail current measured at 370 mV following depo-
larizing test pulse to +20 mV. n = 8. *P6 0.05, 3-S818L/WT, 10-
S818L/WT versus WT1.5.
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course for 10-S818L/WT appeared to be accelerated compared
with that for WT1.5. To compare the activation time course
simply, we ¢tted tail currents to a single exponential function
[16]. Although the activation time constants for S818L/WT
and 3-S818L/WT were not much di¡erent from those for
WT1.5, the activation time constants for 10-S818L/WT at
each depolarizing potential were signi¢cantly smaller than
those for WT1.5 (Fig. 4D). Thus, a 10-fold excess of S818L
cRNA accelerated the activation time course of the HERG
channel.
To analyze accurately the deactivation time course, long
hyperpolarizing test pulses were applied after a depolarizing
conditioning pulse (Fig. 5A). Fig. 5B represents superimposed
traces of expressed currents for WT1.5 and 3-S818L/WT. De-
activating currents for 3-S818L/WT appeared to be acceler-
ated compared with those for WT1.5. Deactivating currents
during test pulses could be ¢tted to a double exponential
function. At all test potentials, the fast and slow time con-
stants for 3-S818L/WT and 10-S818L/WT were signi¢cantly
smaller than those for WT1.5 (Fig. 5C,D). Thus, excess
amounts of S818L cRNAs accelerated the deactivation time
course of the HERG channel.
The steady-state inactivation was evaluated using a double
pulse protocol as described previously [15,16,24]. Fig. 6 shows
the steady-state inactivation curves for WT1.5, 3-S818L/WT
and 10-S818L/WT. The voltage dependence of steady-state
inactivation for 3-S818L/WT and 10-S818L/WT (V1=2 values
were 387.2 þ 1.7 mV [n = 8], and 385.7 þ 0.9 mV [n = 8], re-
spectively) were not much di¡erent from that for WT1.5
(V1=2 : 386.2 þ 3.9 mV [n = 6]). Inverse slope factors for
3-S818L/WT and 10-S818L/WT (330.6 þ 1.3 mV [n = 8], and
331.0 þ 1.2 mV [n = 8], respectively) were also comparable
with that for WT1.5 (330.1 þ 1.0 mV [n = 6]). Thus, excess
amounts of S818L cRNAs did not a¡ect the steady-state in-
activation of HERG channel.
We next evaluated the time course of inactivation (test
pulses: 340 to +20 mV) and recovery from inactivation
(test pulses: 3130 to 350 mV) as described previously
[15,16]. At all test potentials, the time constants of inactiva-
tion and recovery from inactivation for 3-S818L/WT and 10-
S818L/WT were not much di¡erent from those for WT1.5.
Thus, the time course of inactivation and recovery from in-
activation were not a¡ected by excess amounts of S818L
cRNAs (data not shown).
4. Discussion
4.1. Characterization of the loss of HERG channel function by
S818L mutation
The role of the C-terminus on HERG channel function is
Fig. 3. Modi¢cation on the HERG current by coinjection of excess amounts of S818L cRNAs with WT cRNA. A^C: Expressed currents for
WT1.5 (A), those coinjected with 3-fold (4.5 ng) S818L cRNA and 1.5 ng WT cRNA (3-S818L/WT) (B), those coinjected with 10-fold (15 ng)
S818L cRNA and 1.5 ng WT cRNA (10-S818L/WT) (C). The voltage protocol is illustrated in the inset in C. Upper panels: depolarizing test
pulses between 370 and 320 mV; lower panels: depolarizing test pulses between 310 and +20 mV. D: I^V relationships for peak currents re-
corded during depolarizing pulses for WT1.5 (F), 3-S818L/WT (b) and 10-S818L/WT (a). E: I^V relationships for amplitudes of tail currents
for WT1.5, 3-S818L/WT and 10-S818L/WT. F: Normalized I^V relationships for amplitudes of tail currents for WT1.5, 3-S818L/WT and 10-
S818L/WT.
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not yet clari¢ed, mainly because none of the reported mutants
in the HERG C-terminus can form functional homotetrameric
channels, jeopardizing the kinetic analyses. The S818L muta-
tion also cannot form functional homotetrameric channels.
However, new insight into the e¡ects of the HERG C-termi-
nus on HERG channel kinetics could be provided by the
coinjection experiments of S818L cRNA and WT HERG
cRNA. While coinjection of equal amounts of S818L cRNA
with WT cRNA into oocytes did not exhibit apparent domi-
nant-negative suppression, coinjection of excess amounts of
S818L cRNAs with WT cRNA into oocytes decreased
HERG current amplitudes and shifted the voltage dependence
of activation to negative potentials, accelerated its activation
and deactivation, suggesting that S818L subunits can, at least
in part, coassemble with WT subunits to form heterotetramer-
ic functional channels.
These ¢ndings resemble the observations of a HERG C-
terminal splice variant (HERGuso) reported by Kupershmidt
et al. [26]. They reported that HERGuso, which is abundantly
expressed in human heart, modi¢ed HERG current by de-
creasing its amplitude, accelerating its activation, and shifting
the voltage dependence of activation to negative potentials
when WT HERG cDNA and a 10-fold excess of HERGuso
cDNA were cotransfected heterologously to a mammalian cell
line. The similarity of the behaviors between mutant S818L
and HERGuso may support the notion that the HERG C-
terminus includes a domain critical for faithful recapitulation
of the HERG/IKr current. In addition, the HERG C-terminus
may contain a domain involving the activation^deactivation
process of the channel. For other voltage-dependent potassi-
um channels with six transmembrane domains, the impor-
tance of the C-terminus just downstream of the sixth trans-
membrane domain for channel activation^deactivation is also
claimed [27]. These ¢ndings may provide the molecular clue
for elucidating structure^function relationships of the HERG
C-terminus.
What are the possible molecular mechanisms underlying the
¢nding that not equal amounts of S818L cRNA but excess
amounts of S818L cRNAs modi¢ed HERG currents? There
could be some potential explanations; S818L cRNA is not
equally translated or rapidly degrades compared with WT
cRNA. Alternatively, S818L protein is not equally synthesized
or rapidly degrades compared with WT protein. Zhou et al.
[17] have reported that Y611H protein rapidly degrades com-
pared with WT HERG protein. And recently, Kagan et al.
[22] reported that coexpression of A561V with WT HERG
reduces the WT HERG protein expression level by decreasing
WT HERG protein synthesis and increasing its turnover rate.
It remains to be determined, however, if S818L also acts in the
same manner as Y611H or A561V. To delineate these possi-
bilities, Western blotting and/or pulse chase analysis may be
required.
Fig. 4. Acceleration of the HERG current activation by coinjection of a 10-fold excess of S818L cRNA with WT cRNA. A,B: Superimposed
traces of expressed currents for WT1.5 (A) and for 10-S818L/WT (B). A conditioning pulse to activation voltage (0, 20 mV) from a holding po-
tential of 380 mV for varying durations of time from 30 to 600 ms in 30 ms increments was applied, followed by repolarization to 370 mV.
The voltage protocol is illustrated in the inset in C. Currents were not leak-subtracted. Note that scale bars for current amplitudes di¡er be-
tween A and B. C: Normalized tail currents at an activation voltage of 0 mV for WT1.5 (F), S818L/WT (E), 3-S818L/WT (b), and 10-S818L/
WT (a). D: Plots of activation time constants as a function of depolarized test potentials. Expressed tail currents for WT1.5, S818L/WT,
3-S818L/WT and 10-S818L/WT could be ¢tted with a single exponential function. DP6 0.05, S818L/WT, 3-S818L/WT, 10-S818L/WT versus
WT1.5.
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4.2. Mechanism for prolongation of cardiac repolarization by
the S818L mutation
When equal amounts of S818L cRNA and WT cRNA,
which would render quantitative analysis feasible, were coin-
jected into oocytes, the S818L mutation did not exhibit ap-
parent dominant-negative suppression, and did not much af-
fect the gating properties of the HERG channel. Thus, in this
mutant, reduction of the quantitative HERG current may be
the underlying mechanism for depressing the outward HERG
current.
Our present and previous studies indicate that the degree of
HERG current suppression in mutations in the HERG C-ter-
minus is less severe than those in mutations in the pore region
[15]. These data are compatible with the clinical data that
mutations in the HERG C-terminus may be less malignant
than mutations occurring in the pore region [23].
Fig. 5. Acceleration of the HERG current deactivation by coinjection of excess amounts of S818L cRNAs with WT cRNA. A,B: Representa-
tive currents were those for WT1.5 (A). Superimposed traces of expressed currents for WT1.5 and 3-S818L/WT (B). Expressed currents for
WT1.5 are represented by bold lines and those for 3-S818L/WT are represented by thin lines. Note that the peak amplitude for 3-S818L/WT
was ¢tted to that for WT1.5. A conditioning pulse to +20 mV for 1.6 s from a holding potential of 380 mV was applied, followed by hyper-
polarizing test pulses between 380 and 360 mV in 10 mV increments for 6 s. The voltage protocol is illustrated in the inset in A. Currents
were not leak-subtracted. Deactivation time constants were measured by ¢tting deactivating currents during test pulses at each potential with
double exponentials. C,D: Fast (C) and slow (D) components of deactivation time constants for WT1.5 (F), S818L/WT (E), 3-S818L/WT (b)
and 10-S818L/WT (a) as a function of test potentials. DP6 0.05, S818L/WT, 3-S818L/WT, 10-S818L/WT versus WT1.5.
C
Fig. 6. Coinjection of excess amounts of S818L cRNAs with WT
cRNA did not a¡ect the steady-state inactivation of HERG chan-
nel. To examine steady-state inactivation, prepulse potentials be-
tween 3120 mV and +20 mV in 10 mV increments for 45 ms were
applied after a depolarizing pulse to +20 mV for 900 ms, followed
by a common test pulse to +20 mV. The voltage protocol is illus-
trated in the inset. The peak current amplitudes during test pulses
were plotted as a function of the previous prepulse potentials (Vp).
At negative potentials, the currents decline due to the signi¢cant
closing of channels through deactivation. Thus, this was corrected
for by extrapolating the falling phase back to the start of the nega-
tive prepulse potentials, and applying the same relative correction to
the initial outward current during the test pulse. Normalized steady-
state inactivation for WT1.5 (F), 3-S818L/WT (b) and 10-S818L/
WT (a) as a function of the prepulse potentials was ¢tted to a
Boltzmann function.
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